Katherine joined HSBC in April 2023 as a US Founding Executive and to lead Life Science & Healthcare for HSBC Innovation Banking. Prior to HSBC, Katherine spent 8 years at SVB Financial Group serving in an Executive leadership position as the US Head of Life Science & Healthcare, including Head of US Healthcare Corporate Banking, Head of US Healthcare Sponsor Finance, Head of US Relationship Banking, and the Executive Sponsor for Institutionally Distributed Leveraged Finance (launched in 2022 alongside SVB Securities).  Katherine’s team managed ~4,200 clients in the US and ~$80B in deposits and investments, amounting to a 75% market share. During this time, Katherine also served on the Board of Directors for SPD Silicon Valley Bank, SVB Financial Group’s Joint Venture headquartered in China.

Prior to HSBC and SVB, Katherine spent time in various leadership roles over the course of a decade at Wells Fargo. Prior to that, she was in equity derivatives at Merrill Lynch Global Markets & Investment Banking in NYC. She started her career at GE Capital and thereafter was accepted onto GE's Corporate Audit Staff. While she grew up in Virginia and graduated with degrees in Economics and Finance at Virginia Tech, Katherine has been based in Boston since 2006. She has also completed Dartmouth’s Tuck Executive Leadership and Strategic Impact Program, Wells Fargo’s Transformational Leadership Program, the Program on Negotiation at Harvard Law School, and the GE Capital Financial Management Program. She is also a certified Six Sigma Black Belt professional.

Katherine is a regular speaker and presenter both internally and for large scale industry conferences and events across the globe (e.g. former keynote presenter for Bio Asia; regular keynote presenter for multiple ChinaFocus Forum events globally; regular presenter for the Bio Investor Forum in San Francisco; former keynote presenter for the NYSE Life Science Forum).  She was also the recipient of American Banker’s “Most Powerful Women: Next” for 2020.

Away from work, Katherine serves on the American Cancer Society’s CEOs Against Cancer team, holds a National Board of Directors position for Women in Bio, and serves on the Board of Advisors for Life Science Cares. She loves long distance endurance training, qualified for the Ironman 70.3 World Championship in 2022, and recently completed her eight Ironman 70.3 race. She has also completed 4 US-based and 1 international Timmerman Traverse program(s) in support of Life Science Cares and the Damon Runyon Cancer Research Foundation, respectively, including a successful summit of Mt. Kilimanjaro in February 2024 that raised $1.2MM for groundbreaking cancer research. She has 3 kids and a very supportive husband!